Sunshine Guojian Pharmaceutical: Net profit of 190 million yuan in the first half of 2025, a year-on-year increase of 46.96%

Sunshine Guojian Pharmaceutical announced that in the first half of 2025, operating revenue was 642 million yuan, a year-on-year increase of 7.61%. Net profit was 190 million yuan, a year-on-year increase of 46.96%. The company plans to distribute a cash dividend of 0.33 yuan for every 10 shares to all shareholders, with a total cash dividend amounting to 20.3539 million yuan, accounting for 10.69% of the net profit attributable to ordinary shareholders of the listed company in the consolidated financial statements for the first half of 2025